← Open Payments lookup

STEPHANIE SLOUGH: Open Payments

NPI 1124539895 · COMMERCE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$794 in 45 payments from 19 companies in 2025. Trend: 2023 $817 · 2024 $689 · 2025 $794

Food & beverage: $794
CompanyPaymentsAmount
GlaxoSmithKline, LLC.9$135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$101
Teva Pharmaceuticals USA, Inc.5$88
PFIZER INC.3$75
Novo Nordisk Inc4$70
AstraZeneca Pharmaceuticals LP4$69
ABIOMED1$39
ABBVIE INC.2$33
Lundbeck LLC1$22
Viatris Specialty LLC1$20

Products named: TRELEGY ELLIPTA, CAPLYTA, AUSTEDO XR, ELIQUIS, BREZTRI, REXULTI, Ozempic, YUPELRI.

Industry payments across TX — which companies pay providers there.